Viewing Study NCT03452033


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-02-11 @ 7:44 PM
Study NCT ID: NCT03452033
Status: COMPLETED
Last Update Posted: 2022-07-12
First Post: 2018-02-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: H-1337 Ophthalmic Solution Phase 1/2
Sponsor: Allysta Pharmaceutical
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glaucoma, Open-Angle View
Keywords:

Keywords

Keyword Brief Keyword Text View
None glaucoma View